- Home
- EXE vs TECH Comparison
EXE vs TECH Comparison
Compare EXE & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXE
- TECH
- Stock Information
- Founded
- EXE 1989
- TECH 1976
- Country
- EXE United States
- TECH United States
- Employees
- EXE N/A
- TECH N/A
- Industry
- EXE
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXE
- TECH Health Care
- Exchange
- EXE NYSE
- TECH Nasdaq
- Market Cap
- EXE 24.7B
- TECH 7.9B
- IPO Year
- EXE 1993
- TECH 1989
- Fundamental
- Price
- EXE $112.79
- TECH $49.94
- Analyst Decision
- EXE Strong Buy
- TECH Buy
- Analyst Count
- EXE 17
- TECH 9
- Target Price
- EXE $123.76
- TECH $73.88
- AVG Volume (30 Days)
- EXE 3.1M
- TECH 2.1M
- Earning Date
- EXE 04-29-2025
- TECH 05-07-2025
- Dividend Yield
- EXE 2.04%
- TECH 0.64%
- EPS Growth
- EXE N/A
- TECH N/A
- EPS
- EXE N/A
- TECH 0.83
- Revenue
- EXE $6,568,000,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- EXE $158.16
- TECH $8.19
- Revenue Next Year
- EXE $9.99
- TECH $8.61
- P/E Ratio
- EXE N/A
- TECH $60.22
- Revenue Growth
- EXE 35.62
- TECH 4.72
- 52 Week Low
- EXE $69.12
- TECH $46.44
- 52 Week High
- EXE $114.03
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- EXE N/A
- TECH 44.19
- Support Level
- EXE N/A
- TECH $46.77
- Resistance Level
- EXE N/A
- TECH $50.81
- Average True Range (ATR)
- EXE 0.00
- TECH 2.02
- MACD
- EXE 0.00
- TECH 0.41
- Stochastic Oscillator
- EXE 0.00
- TECH 46.82
About EXE EXPAND ENERGY CORPORATION
Expand Energy Corp independent natural gas producer in the United States. It is fueling a more affordable, reliable and lower-carbon future. The group focused on developing abundant natural gas, oil, and gas liquids to expand energy access.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.